Kymera Therapeutics to Present in Fireside Chat at the Guggenheim Healthcare Conference

January 31, 2024

https://www.globenewswire.com/news-release/2024/01/31/2820954/0/en/Kymera-Therapeutics-to-Present-in-Fireside-Chat-at-the-Guggenheim-Healthcare-Conference.html

WATERTOWN, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ:KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in a fireside chat at the Guggenheim 6th Annual Biotechnology Conference in New York, NY on February 7, 2024, at 9:30 a.m. ET.

Read more at globenewswire.com

Related news for (KYMR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.